Phase 2B Study on Safety and Therapeutic Efficacy of DAS181 in Adult Subjects With Naturally Acquired Influenza
Clinical trial NCT01740063 · COMPLETED
Trial details
- NCT number
- NCT01740063
- Sponsor
- Ansun Biopharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2014-01-01
- Enrollment
- 423
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.